Template:Ramipril: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
__NOTOC__
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Ramipril|{{fontcolor|#6C7B8B|Ramipril}}]]'''''
{{SB}} ALTACE<sup>®</sup> Prilace<sup>®</sup>  Ramipro<sup>®</sup>  Tritace<sup>®</sup> Altace<sup>®</sup>  Ramitens<sup>®</sup>  Ampril<sup>®</sup>  Corpril<sup>®</sup>  Piramil<sup>®</sup>  Prilinda<sup>®</sup> Ramace<sup>®</sup> Altace<sup>®</sup> <ref name="dailymed.nlm.nih.gov">{{Cite web  | last = | first =  | title = ALTACE (RAMIPRIL) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fc34cd8-86e6-4034-73bd-4263a68ba046 | publisher = | date =  | accessdate = }}</ref>
|-
{{Ramipril}}
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ALTACE<sup>®</sup> FDA Package Insert
 
|-
==References==
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril indications and usage|Indications and Usage]]
 
|-
{{Reflist|2}}
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril dosage and administration|Dosage and Administration]]
 
|-
[[Category:Cardiovascular Drugs]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril contraindications|Contraindications]]
[[Category:Drugs]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril warnings and precautions|Warnings and Precautions]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril adverse reactions|Adverse Reactions]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril drug interactions|Drug Interactions]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril use in specific populations|Use in Specific Populations]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril overdosage|Overdosage]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril description|Description]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril clinical pharmacology|Clinical Pharmacology]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril clinical studies|Clinical Studies]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril how supplied storage and handling|How Supplied/Storage and Handling]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril patient counseling information|Patient Counseling Information]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Ramipril labels and packages|Labels and Packages]]
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Ramipril
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
|-
|}

Revision as of 20:01, 22 April 2014

Synonyms / Brand Names: ALTACE® Prilace® Ramipro® Tritace® Altace® Ramitens® Ampril® Corpril® Piramil® Prilinda® Ramace® Altace® [1]

Synonyms / Brand Names: ALTACE® Prilace® Ramipro® Tritace® Altace® Ramitens® Ampril® Corpril® Piramil® Prilinda® Ramace® Altace® [1] Template loop detected: Template:Ramipril

References

  1. 1.0 1.1 "ALTACE (RAMIPRIL) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]".

References